NIH-funded research R21 grant

A mutation in the NOTCH2 gene causes brittle bones in children.

Official title: A NOTCH2 Mutation Causes Osteogenesis Imperfecta

Funded at University of Connecticut Sch of Med/dnt · NIH-10818325 · Data updated 2026-11-12

This study is looking at how a change in a specific gene can cause brittle bones, and by using mice that have this gene change, researchers hope to learn more about how to help kids with this condition have stronger bones.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Sch of Med/dnt
NIH-funded
Lab location1 site (Farmington, United States)
Project startApril 1, 2023
Project endFebruary 28, 2026
Funding year2024
Award (this year)$212,973
NIH project number5R21AR080642-02
Project IDNIH-10818325 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children, particularly those diagnosed with osteogenesis imperfecta or exhibiting symptoms of skeletal fragility.

Less likely to help

Patients with osteogenesis imperfecta caused by mutations in genes other than NOTCH2 may not benefit from this research.

What this research studies

This research investigates how a specific mutation in the NOTCH2 gene leads to osteogenesis imperfecta, a condition characterized by fragile bones. By studying a mouse model that mimics this genetic mutation, researchers aim to understand the underlying mechanisms that cause skeletal fragility. The project focuses on characterizing the skeletal phenotype and the affected cell lineages in these mutant mice, which could provide insights into potential treatments for affected children. The findings may help identify new therapeutic targets for improving bone health in patients with this genetic disorder.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for children suffering from osteogenesis imperfecta.

How similar studies have gone: While the specific mutation in NOTCH2 is novel, similar research on Notch signaling and bone health has shown promising results in understanding skeletal disorders.

Where this research is happening

  • University of Connecticut Sch of Med/dnt
    Farmington, United States
    Active

Researchers

  • Principal investigator: Canalis, Ernesto — University of Connecticut Sch of Med/dnt
  • Study coordinator: Canalis, Ernesto

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.